≥99% Purity
Lab Tested
COAs
RETATRUTIDE
- Independent COA with every batch
- Ships same day from Australia, express tracked
- Discreet packaging
Additional information
| Dose | 20MG |
|---|---|
| Form | Lyophilised powder |
| Size | Per selected dose |
| Purity | ≥99% (third-party tested) |
| Storage | Cool, dry, away from light |
| Shipping | Same day from Sydney |
Retatrutide 20mg Australia research peptide
Retatrutide 20mg Australia is supplied by PowderPeps as a lyophilised research peptide for in-vitro laboratory use only. The 20mg strength is available to order now. Other dose options (2mg–60mg) can be joined via waitlist as stock comes online. This page is not a personal-use guide, and the material is not for human or veterinary use.
What is Retatrutide?
Retatrutide is a research-use-only, triple agonist incretin-pathway analog engaging GLP-1 + GIP + Glucagon receptors. Investigations probe multi-receptor signaling integration, mitochondrial efficiency, and redox-sensitive responses in vitro. Not intended for diagnostic or therapeutic use.
Common research applications include:
- Triple-receptor incretin/glucagon signaling models
- Energy balance and metabolic stress studies
- Redox and mitochondrial efficiency assessments
Laboratory form
The vial contains a dry, lyophilised powder. It is a catalogue reagent for laboratory work, not a finished consumer product. PowderPeps does not provide reconstitution advice for self-administration or any dosing guidance. Research use only (RUO) applies to every order on this listing.
Purity, COA, and Australian testing
Checks do not stop at a supplier certificate. After each batch arrives in Australia, samples go through independent testing via Apex Labs to verify identity (confirmed) and purity before release for dispatch. The current published retatrutide 20mg australia batch is Batch Feb 26 (Apex Labs; COA reported 22 Sep 2026), with HPLC purity 99.24% and potency 19.7 mg.
The release target is at least 99%. A certificate of analysis belongs to one batch. Match the number on your vial to the file on our COAs page. If that lot is not published yet, email hello@powderpeps.com with the code from the label rather than borrowing another batch’s PDF.
Retatrutide 20mg Australia specs
Copy these points when you log the retatrutide 20mg australia line into a purchasing note. They describe what PowderPeps ships. They are not a method and they are not a claim about any outcome.
- Form: lyophilised powder
- Available dose (in stock): 20mg
- Other doses: waitlist (2mg–60mg)
- Purity target: at least 99% (third-party tested); current published result 99.24% (HPLC), potency 19.7 mg
- Current batch reference: Batch Feb 26 (Apex Labs; reported 22 Sep 2026)
- Testing path: arrival in Australia, Apex Labs check, then release
- Use: laboratory research only — not for human or veterinary use
Shipping from Sydney
Orders ship same day from Sydney where the cut-off allows. See Shipping & Delivery for AusPost timing and how parcels are packed. Teams ordering retatrutide 20mg australia should place the order before that cut-off when same-day handover matters.
Check the batch before storage
When a parcel arrives, compare the product name, the 20mg strength, and the batch code with the certificate before storage. If they disagree, hold the vial and write to PowderPeps rather than editing the label.
Ordering and the rest of the range
The in-stock listing is retatrutide 20mg australia. Multi-vial options exist on that 20mg strength when a protocol needs more than one vial of that line. Joining a waitlist for another strength does not reserve a date and does not change 20mg stock. Prices and bundle rules are set in the product data, not in this text.
The wider range is listed in the research peptide shop. Each product page carries its own batch notes. Do not copy this certificate across to a different compound.
Published literature
PowderPeps does not turn papers into product claims. Investigators who want the primary literature can use the public index. Start with the PubMed search for retatrutide (opens in a new tab). Those records are third-party publications. They are not instructions for this vial and they are not a basis for personal use.
FAQ
Is Retatrutide in stock in Australia?
Yes for 20mg. Other strengths are on waitlist until they pass the same arrival-and-test sequence.
Where do I confirm the current retatrutide 20mg australia result?
On the COAs page, using Batch Feb 26 for the lot published here (Apex Labs; HPLC 99.24%, potency 19.7 mg; reported 22 Sep 2026). Newer lots are posted when Apex Labs results are released.
Is there a certificate for every batch?
Yes. Testing is completed in Australia via Apex Labs after arrival and before release for dispatch.
Can this be used outside the laboratory?
No. Research use only — not for human or veterinary use. PowderPeps will not advise on personal use.
Where do you ship from?
Sydney, Australia. Eligible orders leave the same day when the cut-off allows. Transit after that follows AusPost.
What if my batch is not on the COAs page yet?
Email hello@powderpeps.com with the lot code from the label. A missing PDF can mean the file is still being uploaded. It does not mean you should use another batch’s certificate.
